eShowcase: LabPas CT 2.5
Phase I package adds formulary accountability, recruitment, lab, and EDC features
Phase I package adds formulary accountability, recruitment, lab, and EDC features
LabPas CT 2.5
Green Mountain Logic (Montpellier, VT) has added formulary accountability, recruitment, clinical lab, and EDC components to LabPas CT, its software package designed for Phase I management. LabPas CT 2.5 deploys PDAs on clinic floors for scanning patient and collection vessel barcodes and RFIDs to eliminate error potential. It provides real-time electronic data entry for collection times, comments, dosing, vital signs, and adverse events, and can adapt to changing protocols.
Enhancements in the latest version of LabPas CT allow users to track and manage the entire fomulary chain including accountability, distribution, reconciliation, returns, and destruction. The package also allows users to manage subject information such as biometrics, and handles scheduling and study assignment tasks. Also, the new clinical lab component of LabPas CT integrates clinical trial results into the study database, and the software exports clinical study data in a variety of formats for easy eCRF creation.
Green Mountain Logic, (866) LABPAS1, www.labpas.com
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
